Index of reports
> Cases with Shock (3)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Curosurf (Poractant Alfa) where reactions include shock. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Curosurf side effects in female
Reported by a physician from China on 2012-01-04
Patient: female
Reactions: Dyspnoea, Pallor, Oxygen Saturation Decreased, Shock
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Curosurf
Dosage: daily dose 120 milligrams;unknown
Indication: Neonatal Respiratory Distress Syndrome Prophylaxis
Start date: 2011-11-07
End date: 2011-11-07
Curosurf
Dosage: daily dose 120 milligrams;unknown
Indication: Oxygen Saturation Abnormal
Start date: 2011-11-07
End date: 2011-11-07
Other drugs received by patient: Mezlocillin (Mezlocillin); Etamsilate (Etamsilate); Cefotiam (Cefotiam); Oxygen (Oxygen); Ambroxol (Ambroxol)
Possible Curosurf side effects in male
Reported by a physician from China on 2012-01-04
Patient: male
Reactions: Peripheral Coldness, Dyspnoea, Rales, Erythema, Pallor, Poor Peripheral Circulation, Sepsis, Oxygen Saturation Decreased, Shock, Infantile Apnoeic Attack
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Curosurf
Other drugs received by patient: Etamsilate (Etamsilate); Cefotiam (Cefotiam); Mezlocillin (Mezlocillin); Ambroxol (Ambroxol)
Possible Curosurf side effects in male
Reported by a physician from China on 2012-01-04
Patient: male
Reactions: LOW Birth Weight Baby, Anaemia Neonatal, Neonatal Respiratory Distress Syndrome, Metabolic Acidosis, Neonatal Pneumonia, Disseminated Intravascular Coagulation, Hyperglycaemia, Jaundice Neonatal, Pulmonary Haemorrhage, Cardio-Respiratory Arrest, Hypocalcaemia, Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Piperacillin W / Sulbactam Sodium (NO Pref. Name)
Dosage: daily dose 0.18 grams;twice a day
Indication: Pneumonia
Start date: 2011-09-19
End date: 2011-09-23
Curosurf
Dosage: daily dose 240 milligrams;daily
Indication: Neonatal Respiratory Distress Syndrome
Start date: 2011-09-19
End date: 2011-09-20
Other drugs received by patient: Haemocoagulase (Haemocoagulase); Etamsilate (Etamsilate); Phenobarbital TAB; Cefodizime (Cefodizime)
|